ATE435008T1 - Polymer-zusammensetzungen und diese enthaltende dosierformen - Google Patents

Polymer-zusammensetzungen und diese enthaltende dosierformen

Info

Publication number
ATE435008T1
ATE435008T1 AT05724660T AT05724660T ATE435008T1 AT E435008 T1 ATE435008 T1 AT E435008T1 AT 05724660 T AT05724660 T AT 05724660T AT 05724660 T AT05724660 T AT 05724660T AT E435008 T1 ATE435008 T1 AT E435008T1
Authority
AT
Austria
Prior art keywords
shell
liquid medium
dosage forms
polymer compositions
forms containing
Prior art date
Application number
AT05724660T
Other languages
English (en)
Inventor
Hai Huang
Der-Yang Lee
Shun Li
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/794,660 external-priority patent/US20050196448A1/en
Priority claimed from US10/794,448 external-priority patent/US20050196442A1/en
Priority claimed from US10/794,449 external-priority patent/US20050196446A1/en
Priority claimed from US10/794,659 external-priority patent/US20050196447A1/en
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE435008T1 publication Critical patent/ATE435008T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05724660T 2004-03-05 2005-03-03 Polymer-zusammensetzungen und diese enthaltende dosierformen ATE435008T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/794,660 US20050196448A1 (en) 2004-03-05 2004-03-05 Polymeric compositions and dosage forms comprising the same
US10/794,448 US20050196442A1 (en) 2004-03-05 2004-03-05 Polymeric compositions and dosage forms comprising the same
US10/794,449 US20050196446A1 (en) 2004-03-05 2004-03-05 Polymeric compositions and dosage forms comprising the same
US10/794,659 US20050196447A1 (en) 2004-03-05 2004-03-05 Polymeric compositions and dosage forms comprising the same
PCT/US2005/007155 WO2005087203A1 (en) 2004-03-05 2005-03-03 Polymeric compositions and dosage forms comprising the same

Publications (1)

Publication Number Publication Date
ATE435008T1 true ATE435008T1 (de) 2009-07-15

Family

ID=34962592

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05724660T ATE435008T1 (de) 2004-03-05 2005-03-03 Polymer-zusammensetzungen und diese enthaltende dosierformen

Country Status (7)

Country Link
EP (1) EP1729738B1 (de)
AT (1) ATE435008T1 (de)
BR (1) BRPI0507439A (de)
CA (1) CA2556922C (de)
DE (1) DE602005015198D1 (de)
MX (1) MXPA06010003A (de)
WO (1) WO2005087203A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6790459B1 (en) * 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin

Also Published As

Publication number Publication date
BRPI0507439A (pt) 2007-07-03
WO2005087203A1 (en) 2005-09-22
CA2556922C (en) 2012-05-15
EP1729738B1 (de) 2009-07-01
DE602005015198D1 (de) 2009-08-13
CA2556922A1 (en) 2005-09-22
MXPA06010003A (es) 2007-03-21
EP1729738A1 (de) 2006-12-13

Similar Documents

Publication Publication Date Title
BRPI0416613A (pt) composição e forma de dosagem compreendendo uma molécula anfifìlica como um veìculo de suspensão
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
MA39059A1 (fr) Système d'administration de médicament.
DE69923786D1 (de) Dünner polymerfilm als medikamentenreservoir
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
BRPI0714399B8 (pt) composição farmacêutica líquida oral
ATE426619T1 (de) Líslichkeit von cellulose in ionischen flussigkeiten unter zugabe von aminbase
ECSP088461A (es) Composiciones farmacéuticas que contienen buprenorfina
NO20023866D0 (no) Farmasöytisk preparat
BRPI0509146B8 (pt) sistema de liberação de droga, método de fabricação do mesmo, e, uso do sistema de liberação de droga
AR047928A1 (es) Derivados de tetrahidropiridoindol
TW200716202A (en) Pediatric formulation of topiramate
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
WO2004028504A8 (en) Modified release dosage forms
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
DOP2006000231A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
AR061165A1 (es) Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
ATE435008T1 (de) Polymer-zusammensetzungen und diese enthaltende dosierformen
EP1867332A4 (de) Pharmazeutische zusammensetzung und verfahren unter verwendung eines antimykotischen mittels in kombination
EA200700217A1 (ru) Фармацевтическая композиция в форме таблетки для нахождения в желудке, содержащая активное вещество
RU99127483A (ru) Способ бальзамирования анатомических препаратов силоксановыми композициями

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties